2 Declaration I, Preneshni Rochelle Naicker, hereby declare that the work contained in this assignment is my original work and that I have not previously submitted it, in its entirety or in part, at any university for a degree. The ability to form biofilms contributes significantly to the virulence of Staphylococcus aureus. Virulence factors may be associated with certain S. aureus lineages. However, the contribution of the genetic background of S. aureus to biofilm formation is poorly understood. This study investigated the association between the genetic background and the biofilm forming ability of clinical invasive S. aureus isolates. Secondary objectives included investigating any correlation with biofilm formation and methicillin resistance or the source of bacteraemia.
INTRODUCTION
Staphylococcus aureus has ensured its success as an important pathogen worldwide through its versatility, virulence factors and resistance mechanisms. Invasive S. aureus infections have a high mortality rate and infections with methicillin-resistant S. aureus (MRSA) have even poorer outcomes (Lowy, 1998; Cosgrove & Fowler, 2008) . Biofilm formation is a major virulence factor of S. aureus.
A biofilm is 'an assemblage of surface-associated microbial cells that is encased in an extracellular polymeric substance matrix' (Donlan, 2002) . These unique communities form on various indwelling medical devices. Bacteria embedded in a biofilm are more resistant to antimicrobials through several mechanisms. Overall antimicrobial penetration is poor, growth-dependent agents have decreased efficacy due to the slower metabolic state of the bacteria and exchange of resistance genes is easier due to the close proximity of cells. Formation of persister-cells, a subpopulation of bacteria that survive antimicrobial treatment, is also a contributing factor (Cramton & Gotz, 2004) .
Due to advances in the medical field, prosthetic devices are increasingly used in patient management. Biofilms may develop on intravascular catheters, prosthetic heart valves and orthopaedic implants. They become reservoirs for persistent infections and foci for metastatic complications such as endocarditis, deep tissue abscesses, septic arthritis, and osteomyelitis (Costerton et al., 1999; Chu et al., 2005) . Definitive management of device-related infection frequently requires removal or replacement of the prosthetic material.
The best-described mechanism of biofilm development in S. aureus involves the extracellular molecule polysaccharide intercellular adhesin or poly-Nacetylglucosamine (PIA/PNAG) (Mack et al., 1996) . PIA/PNAG synthesis is regulated by the intercellular adhesion (ica) locus (Cramton et al., 1999) . PIA/PNAG and ica-independent biofilm formation, particularly in MRSA, has also been described (Fitzpatrick et al., 2005; O'Neill et al., 2008) .However, the relationship between biofilm formation and the genetic background of S. aureus is poorly understood. Different clonal lineages of S. aureus may have different biofilm forming capabilities. In the recent literature, differences in biofilm formation were found to be due to the staphylococcus protein A (spa) lineage (Atshan et al., 2012a) . Other studies found strong biofilm formation correlated with multilocus sequence typing (MLST) clonal complexes (Croes et al., 2009) or Staphylococcal Chromosome Cassette mec (SCCmec) typing (Lim et al., 2013) .
This study investigated the association between the genetic background and the biofilm forming ability of clinical invasive S. aureus isolates. In addition, we investigated any correlation with biofilm formation and methicillin resistance or source of bacteraemia.
METHODS
Setting & Design. This was a prospective, descriptive study conducted at the National Health Laboratory Service (NHLS) Microbiology Laboratory, Tygerberg Hospital, which is a 1300-bed tertiary referral hospital in Cape Town, South Africa.
Bacterial strains. S. aureus isolates obtained from pure blood cultures between January 2010 and January 2012 were included. Positive blood cultures were identified using the BACTEC 9240 system (Becton Dickinson, USA). Identification of S. aureus was done using Mannitol Salt agar (MSA) and DNase agar plates or Vitek 2 (bioMérieux, Marcy l'Etoile, France). Kirby-Bauer disk diffusion antimicrobial susceptibility testing was performed and Vancomycin Minimum Inhibitory Concentrations (MIC) were determined using ETests (bioMérieux, France) for all MRSA isolates. Clinical and Laboratory Standards Institute (CLSI) 2010 and 2011 interpretative criteria were used. Isolates were stored on Microbeads in cryobroth at -70°C until defrosted and sub-cultured onto blood agar plates for use in this study.
Genotypic characterization. Pulsed-field gel electrophoresis (PFGE) is considered the reference standard for S. aureus strain typing and is the most discriminatory typing method (Deurenberg et al., 2007; Oosthuysen et al., 2013) . The method described by McDougal et al. was followed (McDougal et al., 2003) . The clones were classified based on the number of isolates and unique PFGE types as major (> 10 isolates per PFGE type), intermediate (4-9 isolates per PFGE type) or minor (2-3 isolates per PFGE types). In addition, spa typing and SCCmec typing were also performed (Harmsen et al., 2003; Milheirico et al., 2007) . MLST was performed on a representative set of isolates from each major PFGE cluster (Enright et al., 2000) .
Isolate selection. From a total collection of 208 non-repeat isolates, blood culture isolates were selected from each major, intermediary and some minor PFGE clusters. Different spa types within the same cluster were also selected. For MRSA isolates, isolates from the same PFGE clusters and spa type were only selected if they were different on SCCmec typing. To include more PFGE clusters, a singleton and different spa types, 2 isolates were included even though MLST data was not available (Table  1) .
MLST CC
MLST ST spa-CC spa types SCCmec CC1 (4) ST1 (4) cc174(4) t5471, t174, t8637, t127
ST5 ( -- Table 1 . Genotypic characteristics of strains *Number in parentheses (if >1) Biofilm assay. Thirty genotypically unique strains were assessed for phenotypic biofilm formation with the microtitre plate assay as described by Christensen et al and modified by O'Neill et al (Christensen et al., 1985; O'Neill et al., 2007) . Briefly, S. aureus was grown overnight in Brain Heart Infusion (BHI) broth. The culture was diluted 1:200 in fresh BHI broth. An amount of 200µL was added to a 96-well polystyrene tissue-culture treated microtitre plate (Costar® 3595, Corning Incorporated, NY, USA) and incubated at 37°C for 24 hours. After overnight incubation the wells were manually rinsed three times with Phosphate-Buffered Saline (PBS), using a hand-held pipette. The plates were air-dried at 60°C for one hour to fix the remaining cells. These were then stained with 0.4% Crystal Violet for two minutes and the plate was rinsed three times with PBS once again. The optical density was measured with a MicroELISA plate reader at a wavelength of 490nm (iMark Microplate Absorbance Reader, Bio-Rad, USA). All isolates were tested in triplicate and an average optical density was determined. A cutoff of 0.17 was used as it was three standard deviations above the mean for a clean tissue culture plate stained as above. Isolates with A 490 ≤ 0.17 were considered non-adherent. A 490 > 0.17 was considered Weak positive and A 490 > 0.34 Strong positive (twice the cutoff value). S. epidermidis ATCC 35984 (American Type Culture Collection, Virginia USA) and Brain Heart Infusion broth were used as positive and negative controls respectively. Clinical data. Clinical information was obtained by clinical consultation with the attending doctor as part of the routine microbiology service for all positive blood cultures. Informed consent was obtained from patients and clinical data was stored in a database with study numbers used for patient confidentiality. Folder reviews were conducted for select cases where insufficient clinical information was gathered. The source of bacteraemia was determined according to the clinical presentation, radiological features and bacteriological factors i.e. the isolation of S. aureus from specimens from the site of infection . The categories were defined as follows: skin and soft tissue (SSTI) was the clinical presentation of soft tissue inflammation together with bacteraemia. Catheter-related blood stream infection (CRBSI) was determined by the culture of S. aureus from the catheter tip (>10 2 cfu) and/or clinical evidence of catheter related infection. Pneumonia (PNEUM) was the isolation of S. aureus from the respiratory tract with compatible radiological features. Modified Duke's criteria was used to define infective endocarditis (IE). Bone and joint (B&J) was clinical and radiological features of osteomyelitis or septic arthritis. Vascular (VASC) was clinical evidence of endovascular infection and intraabdominal (IA) was defined as clinical and radiological evidence of deep-seated intraabdominal source with S. aureus cultured from the site (Liao et al., 2008) .
Statistical analysis. ANOVA with Bonferroni-adjusted post-hoc tests and t-tests were used for statistical analysis (Statistica version 10, 2011). The biofilm forming ability was analyzed by methicillin resistance, source of bacteraemia, spa, SCCmec and MLST type. Statistical significance was defined as p <0.05.
Ethics. This study received ethical approval from the Division of Research Development and Support, Stellenbosch University (N09/01/012).
RESULTS

A. Description of isolates
The 30 isolates selected comprised of 19 PFGE clusters, with 28 spa types and 15 MLST sequence types (ST). These were from 9 spa-clonal complexes (spa-CC) and 9 MLST clonal complexes (MLST CC) ( There were 9 MRSA (30%) and 21 methicillin-sensitive S. aureus (MSSA) (70%). The source of infection was determined for all the S. aureus bacteraemias (Figure 1 ). Ten originated from skin and soft tissue infections (SSTI), 9 from catheter-related blood-stream infections (CRBSI), 3 pneumonias (PNEUM), and 2 each from infective endocarditis (IE), bone and joint (B&J), vascular (VASC) and intra-abdominal (IA). Biofilm formation occurred in 57% of isolates (Figure 2 ). Weak biofilm formation occurred in 40% (n=12) and strong biofilm formation in 17% (n=5) of isolates. Thirteen isolates were classified as non-adherent. The reproducibility of the assay was excellent. 
i) spa typing
The spa types t701, t1275, t1443, t1476 and t2360 were strong biofilm producers. There were too many individual spa types for further analysis.
All 5 isolates capable of strong biofilm formation belong to one spa clonal complex (spa-CC 064). Strains from spa-CC 064 were capable of higher biofilm formation than all other spa clonal complexes (p=0.00002) (Figure 3) . There were only 9 MRSA isolates for SCCmec typing and further analysis could not be performed.
iv) PFGE
As PFGE strain typing was the basis of selection of isolates, biofilm formation could not be analysed by PFGE clusters due to the large variation.
C. Analysis by methicillin resistance
There were no significant differences observed in biofilm formation of MRSA isolates compared with MSSA isolates (p=0.9) (Figure 7 & 8) . 
D. Analysis by source of bacteraemia
There were no differences in biofilm formation relating to the source of bacteraemia (p=0.64). However, as clinically expected, it was observed that VASC and CRBSI infections had higher median optical densities. The sources of bacteraemia for strong biofilm producers were CRBSI, SSTI and VASC (Figure 9 & 10) . 
DISCUSSION
Biofilm-associated infections caused by S. aureus are a significant cause of morbidity and mortality (Archer et al., 2011) . In this study strong biofilm formation was associated with strains from spa-CC 064 and MLST CC 5 and 8. Although MLST CC8 has now been incorporated into MLST CC5, it is considered separately in this analysis . As MLST CC8 in now incorporated into MLST CC5, MLST CC5 may be associated with high biofilm formation. This suggests that certain clones are more prone to biofilm formation and that spa-typing and MLST may be a predictor of biofilm formation.
S. aureus demonstrates predominantly clonal evolution. Virulence factors may be associated with specific S. aureus lineages. Certain virulence factors such as collagen adhesion (CNA) and toxic shock syndrome toxin 1 (TSST1) are known to be associated with certain clonal lineages . Therefore some clones are considered more virulent than others (Melles et al., 2004) . Biofilm formation is also a major virulence factor and several other observations have supported the link between the clonal lineage and biofilm formation.
Atshan et al. found that strains from the same spa type had similar adherence properties on the microtitre plate assay. In another study by the same group, MRSA strains from the same MLST, spa and SCCmec type had similar biofilm forming abilities, however there was more variation by spa type. In contrast to our findings, they found spa type t037 (ST239-CC8-IIIA) strains form strong biofilms (Atshan et al., 2012a,b) . Croes et al. suggested that MLST CC8 was a predisposing factor for a strain to produce strong biofilms (Croes et al., 2009) . Furthermore, the Brazilian clone (also MLST CC8) was shown to have increased adherence (Amaral et al., 2005) . The EMRSA-15 clone in Scotland was found to form stronger biofilms than EMRSA-16 isolates (Smith et al., 2008) .
In two South African academic hospitals it was shown that MRSA bacteraemia had a higher mortality rate than MSSA (Perovic et al., 2006) . The prevalence of MRSA in bacteraemia at Tygerberg hospital has been reported to be 30% , which is reflected in the percentage of MRSA in the collection of strains that we tested. Certain pandemic MRSA clones are spread worldwide. Recent publications describe the ST612-MRSA-IV clone (MLST CC8) as the most widespread MRSA clone in Cape Town, and South Africa (Jansen van Rensburg et al., 2011; Orth et al., 2013; Oosthuysen et al., 2013; Moodley et al., 2010) . In this study ST 612 formed strong biofilms, which may contribute to its dominance in nosocomial infections in South Africa.
Some studies found SCCmec typing a predictor of biofilm formation. SCCmec IV isolates were capable of higher biofilm formation (Kwon et al., 2008) . In contrast to the findings by Lim et al. where SCCmec III was found to be a genetic risk factor for strong biofilm formation (Lim et al., 2013) , we found SCCmec IV isolates produced the strongest biofilms (only three isolates tested). In our study the one SCCmec III isolate did form a weak biofilm. The differences found could also be attributed to the biofilm assay methodology. A larger collection of MRSA isolates should be tested to make any meaningful conclusions. (Kwon et al., 2008) . Other studies showed no difference in biofilm formation between MRSA and MSSA isolates (Smith et al., 2008; Indrawattana et al., 2013) . In our study there was also no difference in biofilm formation between MRSA and MSSA isolates, although the mean optical density for MSSA was higher. Atshan et al. also found MSSA clones had slightly higher biofilm formation than MRSA. Croes et al. found that MRSA or MSSA with an MRSA associated CC, were more capable of strong biofilm formation in the presence of 0.1% glucose. Our study did not supplement glucose which may have affected the MRSA biofilm capabilities. Our selection criteria was based on the genotypic classification which is also a limiting factor as some clones may be associated with methicillin-resistance (Deurenberg et al., 2007) .
Several studies have investigated the source of isolates as a predictor of biofilm formation. Isolates from blood cultures showed a higher frequency of biofilm formation compared to isolates from other sites (Kwon et al., 2008) . In the study by Smith et al., the isolates derived from skin had a greater ability to form fully established biofilms (Smith et al., 2008) . In our study, the source of bacteraemia as established by clinical data for S. aureus blood-stream infections was not a predictor of biofilm formation. However, we only tested blood culture isolates, these being the most clinically important specimens, and did not collect isolates from the source of infection.
The variations in biofilm capacity may be due to differences in surface proteins or gene expression in different S. aureus clonal lineages. Microarray analysis showed variation between different lineages is, in particular, due to surface adhesion genes and their regulators. However there were no specific genes to differentiate carriage versus invasive isolates (Lindsay et al., 2006) . Kuhn et al. also found no difference with adhesion genes in epidemic and sporadic MRSA clones (Kuhn et al., 2006) . Gene expression studies and whole genome sequencing may assist to elucidate the reason for these differences (Costa et al., 2013) .
The strength of this study was that biofilm formation was tested on a collection of genotypically well characterized strains, all of them isolated from blood cultures. They were selected to be genetically diverse. PFGE, the gold standard for S. aureus strain typing, was the basis of the selection to ensure that we did not test the same strain as outbreaks of MRSA may occur in hospital settings. Strains within the same PFGE cluster were chosen if they were different spa or SCCmec types. The limitations were the small numbers included. By testing more isolates we could have also assessed if certain spa-types are more prone to biofilm formation. Another limiting factor was not using supplementary glucose in the biofilm assay. This may influence the MRSA biofilm formation (Croes et al., 2009; O'Neill et al., 2007) . Although we did analyse our collection by methicillin resistance and source of bacteraemia, these were secondary objectives. The limitation of selecting isolates based on their genetic background is that conclusions cannot be made about methicillin resistance and source of bacteraemia. Further studies should be conducted with different selection criteria to specifically address these questions. Further investigations for the presence of adhesion genes, gene expression and accessory gene regulator (agr) groups are required.
Biofilm formation correlates with genetic background in our population of invasive S. aureus strains. The propensity to form biofilms may be linked to the epidemic potential of certain successful clones of S. aureus. The spa lineage may serve as a genetic predictor of biofilm formation. MLST can also be used to determine clones with higher biofilm formation. Further studies are required to identify these clones with high biofilm formation and investigate the prevalence and expression of adhesion genes.
